Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Condition:   Uncomplicated Plasmodium Falciparum Malaria Interventions:   Drug: KAF156;   Drug: LUM-SDF Sponsors:   Novartis Pharmaceuticals;   European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials